Skip to main content
Clinical Trials/NCT07576985
NCT07576985Enrolling By InvitationNot Applicable

Evaluating the Efficacy of Intravenous Acetaminophen (IV Tylenol) in Reducing Pain and Agitation in Pediatric Patients Undergoing Elective Tonsillectomy and/or Adenoidectomy

MetroHealth Medical Center1 site in 1 country20 target enrollmentStarted: April 21, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
20
Locations
1

Study Overview

Brief Summary

MetroHealth's main campus administers IV Tylenol as part of its pain management protocol for elective tonsillectomy/adenoidectomy, whereas Parma campus does not. Comparing these practices provides an opportunity to evaluate the benefits of IV Tylenol for pain, agitation, and associated secondary outcomes in this population. The pain/agitation would be assessed with a validated tool PAED and FLACC

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 8 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects pediatric patients aged ≤7 years, observed by study team who will complete the scales
  • Undergoing elective tonsillectomy and adenoidectomy.

Exclusion Criteria

  • Pre-existing neurological or developmental disorders impacting pain/agitation scores

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Bushra Abdul Aleem

Principal Investigator - Pediatric Anesthesiologist

MetroHealth Medical Center

Study Sites (1)

Loading locations...

Similar Trials